Page 7,186«..1020..7,1857,1867,1877,188..7,2007,210..»

Fidelity's O'Hanley talks of sex, drugs and revolution

Posted: Published on February 3rd, 2012

BOSTON (Reuters) - Ronald O'Hanley has emerged as an outspoken force inside Fidelity Investments, giving a speech on Thursday that touched on sex, drugs and revolution as he warned that young Americans face getting a raw deal from the U.S. retirement system. Top executives at the Boston-based mutual fund giant are known for being conservative and scripted in their public appearances. But since O'Hanley joined Fidelity in 2010 as the president of asset management and corporate services, he has demonstrated a more free-wheeling approach in his public comments. The United States is facing a "real crisis in intergenerational inequity," O'Hanley said in explaining how Social Security's cash deficits continue to grow as retirees outnumber the people entering the workplace. The crucial question that faces O'Hanley's college-age son and his friends, he said, is what kind of retirement system they will have when they grow old. The United States is at the tipping point in dealing with problems affecting the retirement savings system, O'Hanley said. If the country doesn't deal with the issues now, he added, there will be a more severe crisis 10 to 15 years from now, such as a significant increase in homelessness. "It's a truly raw deal … Continue reading →

Posted in Drugs | Comments Off on Fidelity's O'Hanley talks of sex, drugs and revolution

Leslie Carter Overdosed on Several Drugs

Posted: Published on February 3rd, 2012

Leslie Carter overdosed and was under the influence of several drugs before her death, according to an incident report obtained by ABCNews.com from officials who responded to her family's 911 call. The report lists three drugs that were found near Carter: Olanzapine, used to treat the symptoms of schizophrenia and bipolar disorder; Cyclobenzaprine, a muscle relaxant; and Alprazolam, used to treat anxiety or panic disorders, also known as Xanax. The report reveals that Ginger Carter, Leslie's stepmother, told authorities that Leslie had "a long history of mental illness and was on medication for her depression." Her stepmother said that Leslie seemed depressed the morning of Jan. 30, and that she fell in the shower. Ginger Carter helped Leslie lie down, at first with Leslie's 10-month-old daughter, and periodically checked on her. Late in the afternoon, she found that Leslie was not breathing. Robert Carter, Leslie's father, tried to perform CPR on her, and Leslie's stepmother then called 911. See Leslie Carter's full incident report. Kristy Leibowitz/Getty Images Ginger Carter also appeared to be under the influence of drugs or alcohol or both, according to the incident report. "Ginger had slurred speech, pinpoint pupils, glassy eyes and kept falling asleep," the … Continue reading →

Posted in Drugs | Comments Off on Leslie Carter Overdosed on Several Drugs

Priligy Dapoxetine – Video

Posted: Published on February 3rd, 2012

25-11-2011 02:38 Priligy Dapoxetine - link to online store hqdrugshost.com Dapoxetina (Priligy) 60mg Dapoxetine is used for the treatment of premature ejaculation in men. Priligy can be taken with or without food. Take one tablet 1--3 hours before anticipated sexual activity. The astonishing quality of... Originally posted here: Priligy Dapoxetine - Video … Continue reading →

Posted in Online Pharmacy | Comments Off on Priligy Dapoxetine – Video

Lack of Pharmacists in Hospitals Patient Care PIC drug interact.mp4 – Video

Posted: Published on February 3rd, 2012

27-01-2012 06:29 Hospitals Without Hospital Pharmacists Results PIC Deaths PIC Deaths Result of Running Hospitals without adequate number of hospital Pharmacists. LAHORE - The National Drug Policy (NDP) is not being implemented in any of the major city hospitals, Pakistan Today has learnt. The NDP guidelines are being violated as none of the public hospitals across the city is maintaining the standard ratio of one pharmacist for fifty beds, which is affecting the patients and young pharmacy graduates coming into the field. The section number 8.2 of the National Drug Policy states, "It will be the policy objective of the government that the scheme of scientific hospital pharmacy shall be introduced in the country both under the federal and provincial governments. In order to provide efficient health care service, hospital pharmacists shall be appointed in all the hospitals of the country at the rate of one pharmacist for each fifty beds. Efforts will be made to increase the availability of qualified pharmacists for this purpose. The Hospital Pharmacy System will be properly organised on scientific lines under the supervision of graduate pharmacists. They will be assigned with specific duties to provide an efficient drug supply system and where possible a … Continue reading →

Posted in Pharmacy | Comments Off on Lack of Pharmacists in Hospitals Patient Care PIC drug interact.mp4 – Video

Daniel Kraft on Singularity 1 on 1 (part 1) – Video

Posted: Published on February 3rd, 2012

31-01-2012 18:50 http://www.singularityweblog.com This morning I interviewed Daniel Kraft for Singularity 1 on 1. I met Dr. Kraft at Singularity University where he is the Medicine and Neuroscience Chair and executive director of the FutureMed Program. Daniel is one of those people with an incredibly diverse spectrum of talents and interests for he is not only a medical doctor and oncologist but also an inventor, a technology and space enthusiast, an entrepreneur and an F-16 flight surgeon. During our conversation we discuss a variety of topics such as: Daniel's early interest and talent in technology and science; his original fascination with the Apollo Space program and eventual participation in International Space University; his passion for flying and being a pilot; his medical education and personal journey to becoming a faculty member at Singularity University; his desire to be an instigator, connector and motivator of innovation; the story behind as well as the purpose and structure of the FutureMed program; bone marrow harvesting, regenerative medicine and stem cell research; longevity and the future of medicine and health care; his greatest inspiration and concerns about the field of medicine and his belief that one doesn't have to be a doctor to improve … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Daniel Kraft on Singularity 1 on 1 (part 1) – Video

CORRECTING and REPLACING Leading Global Cell Therapy Organizations Support U.S. Department of Justice Appeal of Ruling …

Posted: Published on February 3rd, 2012

MINNEAPOLIS--(BUSINESS WIRE)-- Please replace the release dated January 23, 2012 with the following corrected version due to multiple revisions. The corrected release reads: LEADING GLOBAL CELL THERAPY ORGANIZATIONS SUPPORT U.S. DEPARTMENT OF JUSTICE APPEAL OF RULING ON DONOR COMPENSATION Coalition says PBSC donor compensation poses health risks to patients and donors A coalition of eight leading international health organizations today issued a statement supporting the U.S. Department of Justice’s appeal of the Ninth Circuit Court ruling that allows certain marrow donors to be compensated. Filed Jan. 17, the Justice Department’s appeal cites the potential for serious health risks to patients and donors if the ruling stands. Approximately 5,000 patients each year in the United States receive marrow transplants from unrelated donors to treat leukemia, lymphoma and a number of other diseases. The marrow is a source of stem cells that are critical to restoring the immune system for these patients. Two techniques are used to extract these stem cells. The first draws marrow directly from the donor’s hip bone and the second moves the stem cells out of the bone marrow and into the bloodstream using a stimulating hormone, and then collects peripheral blood stem cells (PBSCs) in a procedure … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on CORRECTING and REPLACING Leading Global Cell Therapy Organizations Support U.S. Department of Justice Appeal of Ruling …

Regenerative Medicine with Placenta Extracts and Stem Cell Therapies – Dr. Janethy Balakrishnan – Video

Posted: Published on February 3rd, 2012

24-08-2009 22:42 This is a preview of Regenerative Medicine with Placenta Extracts and Stem Cell Therapies by Dr. Janethy Balakrishnan at the 2008A4M Orlando Conference. Visit http://www.instatapes.com to purchase this lecture and many others on DiGiVision, video and slides synced. Also, visit http://www.worldhealth.net for the conference sponsor. Item #A5M-081W07 Visit link: Regenerative Medicine with Placenta Extracts and Stem Cell Therapies - Dr. Janethy Balakrishnan - Video … Continue reading →

Comments Off on Regenerative Medicine with Placenta Extracts and Stem Cell Therapies – Dr. Janethy Balakrishnan – Video

Statement – Rx&D Applauds Government of Canada for Investing in Personalized Medicine

Posted: Published on February 3rd, 2012

OTTAWA , Feb. 1, 2012 /CNW/ - The following is a statement by Russell Williams , President of Canada's Research-Based Pharmaceutical Companies (Rx&D) on the announcement by the Government of Canada today to ensure that personalized medicine will allow for more effective treatments, thus supporting our Canadian health care system in a more sustainable way. "Canada's Research-Based Pharmaceutical Companies welcome this commitment by the Government of Canada to establish personalized medicine as the way to transform the delivery of health care to patients. "At Rx&D, we believe that providing the right medicine with the right dose to the right patient at the right time is crucial to improving health outcomes for Canadians. With the rise of chronic disease and an aging population, all governments are grappling with unprecedented demand for health care services. It is clear that we face a collective challenge to sustain and improve our health care system where traditional approaches are no longer efficient. "We commend the Government of Canada's commitment to engage in this work. Pharmaceutical innovation is a proven tool to help Canadians live longer, healthier, more productive lives. It is critical to the future productivity of our country, our workplaces, our communities and our … Continue reading →

Comments Off on Statement – Rx&D Applauds Government of Canada for Investing in Personalized Medicine

CORRECTING and REPLACING Leading Global Cell Therapy Organizations Support U.S. Department of Justice Appeal of Ruling …

Posted: Published on February 3rd, 2012

MINNEAPOLIS--(BUSINESS WIRE)-- Please replace the release dated January 23, 2012 with the following corrected version due to multiple revisions. The corrected release reads: LEADING GLOBAL CELL THERAPY ORGANIZATIONS SUPPORT U.S. DEPARTMENT OF JUSTICE APPEAL OF RULING ON DONOR COMPENSATION Coalition says PBSC donor compensation poses health risks to patients and donors A coalition of eight leading international health organizations today issued a statement supporting the U.S. Department of Justice’s appeal of the Ninth Circuit Court ruling that allows certain marrow donors to be compensated. Filed Jan. 17, the Justice Department’s appeal cites the potential for serious health risks to patients and donors if the ruling stands. Approximately 5,000 patients each year in the United States receive marrow transplants from unrelated donors to treat leukemia, lymphoma and a number of other diseases. The marrow is a source of stem cells that are critical to restoring the immune system for these patients. Two techniques are used to extract these stem cells. The first draws marrow directly from the donor’s hip bone and the second moves the stem cells out of the bone marrow and into the bloodstream using a stimulating hormone, and then collects peripheral blood stem cells (PBSCs) in a procedure … Continue reading →

Comments Off on CORRECTING and REPLACING Leading Global Cell Therapy Organizations Support U.S. Department of Justice Appeal of Ruling …

StemCells, Inc. Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial

Posted: Published on February 3rd, 2012

NEWARK, Calif., Feb. 2, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM - News) today announced that the U.S. Food and Drug Administration (FDA) has authorized the initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC(R) product candidate (purified human neural stem cells) in dry age-related macular degeneration (AMD), the most common form of AMD. AMD is the leading cause of vision loss and blindness in people over 55 years of age, and approximately 30 million people worldwide are afflicted with the disease. There are no approved treatments for dry AMD. "With the approval of this trial, we have accomplished something truly unique in the stem cell field, which is the extension of clinical testing of our proprietary human neural stem cell platform to all three elements of the central nervous system: the brain, spinal cord and eye," said Martin McGlynn, President and CEO of StemCells, Inc. "The preclinical data supporting our IND is particularly compelling and we look forward to getting this trial underway." The Phase I/II trial will evaluate the safety and preliminary efficacy of HuCNS-SC cells as a treatment for dry AMD. The trial will be an open-label, dose-escalation study, and is expected to enroll … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on StemCells, Inc. Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial

Page 7,186«..1020..7,1857,1867,1877,188..7,2007,210..»